|
Dr. Vaught is Executive Vice President of the company’s research and development division. He has headed the company's research operations since joining Cephalon in 1991. Prior to joining the company, Dr. Vaught was Assistant Director, CNS Research, for the R.W.J. Pharmaceutical Research Institute, a subsidiary of Johnson & Johnson, a pharmaceutical and consumer products company, and central nervous system therapeutic team leader for Johnson & Johnson from 1989 to 1991.
Dr. Vaught received his Ph.D. in pharmacology from the University of Minnesota. Dr. Vaught has published more than 100 articles in numerous peer-reviewed journals in the field of neurobiology. He currently holds an adjunct academic appointment in the Department of Pharmacology at Temple University, serves on the ASPET Drug Discovery and Development Committee, is a member of the integrated research team for Neuroprotection Advanced Technology Applications for Combat Casualty Care and serves on the Board of Directors of the American Society of Experimental Therapeutics. | 